Companies /Healthcare

AKTS

AKTS Biotechnology
$22.86
▲ $0.15 (+0.66%) today
Markets closed · 5:32am ET
Today · % change

Fundamentals

Market Cap
$1.3B
Revenue (TTM)
$10.1M
EPS (TTM)
$-1.34
52-Week Range
$15 – $34
Street Target
$34.81

About AKTS

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures and sells radio frequency (RF) filter products for the wireless mobile device industry in the United States. The company is headquartered in Huntersville, North Carolina.

AKTS Coverage